Goldman Sachs has initiated coverage of Vera Therapeutics (VERA) with a buy rating, citing its drug candidate atacicept and a ...

Goldman Sachs analyst Paul Choi initiated coverage of Vera Therapeutics (VERA) with a Buy rating and $58 price target Following the recent ...

NEW YORK, Jan 29 (Reuters) - Goldman Sachs (GS.N), opens new tab has hired Daniel Marcu from Amazon.com (AMZN.O), opens new tab as its global head of artificial intelligence engineering and ...

Goldman Sachs staffers are griping about getting paltry bonuses — despite a massive raise given to CEO David Solomon after the bank posted its best earnings in three years, The Post has learned.

NEW YORK (Reuters) - Goldman Sachs on Monday tapped veteran banker Stefan Duffner to lead the investment bank's activism and shareholder advisory work in Europe, Middle East and Africa (EMEA ...

NEW YORK, Jan 29 (Reuters) - The Federal Reserve's future moves on interest rates in 2025 will be in a narrow range unless the trajectory of inflation changes, Goldman Sachs CEO David Solomon said ...

Cost analysis by Goldman Sachs Research suggests at a headline level, the average cost of onshore wind power operating on-site at a US data centre is $25 per megawatt-hour and solar $26 per MWh ...

Goldman Sachs employees are fuming over their scanty bonuses after CEO David Solomon pocketed a $39 million payout for 2024, as the firm earned its highest quarterly profit in three years.